Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Jihye Yun Image

      Jihye Yun, Ph.D.

      Department of Genetics, Division of Discovery Science

      About Jihye Yun

      Jihye Yun, Ph.D., is an Associate Professor in the Department of Genetics at MD Anderson Cancer Center. She received her Ph.D. under the mentorship of Dr. Bert Vogelstein at Johns Hopkins School of Medicine and completed postdoctoral training with Dr. Lewis Cantley at Harvard Medical School and Weill Cornell Medicine as a Damon Runyon Postdoctoral Fellow. During this time, she published two first-author papers in Science, each cited more than 1,000 times and subsequently validated in clinical settings. These foundational studies established her long-standing research focus on how diet and metabolism influence colorectal cancer development.

      In 2018, Dr. Yun launched her independent laboratory at Baylor College of Medicine as a first-time CPRIT Recruitment Awardee and joined MD Anderson in 2022 to further expand the translational impact of her research. Since then, she has established strong collaborations with clinicians and researchers and has led a project within the Colorectal Cancer Moon Shot Program. Her laboratory has published in high-impact journals, including Science and Nature Metabolism, and she has received multiple prestigious awards, including the Pew–Stewart Scholar for Cancer Research Award, the V Scholar Award, and the Sabin Family Foundation Award.

      Dr. Yun’s research aims to define how dietary factors shape colorectal cancer initiation and progression to reduce cancer incidence and mortality. Her laboratory investigates how specific dietary exposures promote tumor development both directly, through metabolic reprogramming of cancer cells, and indirectly, through modulation of the gut microbiome and immune system. By integrating multi-omics approaches with mechanistic mouse models and translational human studies, her team aims to decode the intricate relationships within the diet–microbiota–tumor axis to develop clinically translatable dietary and metabolic strategies for the prevention and treatment of colorectal cancer and other intestinal diseases, including colitis.

      Read More

      In the news

      Sugary drinks may increase risk of metastasis in advanced colorectal cancer

      A silver can pours out brown soda against a yellow background.

      Do sugary drinks increase colorectal cancer risk?

      From left to right, starting at the top: Joseph Arthur, MD; Pavan Bachireddy, MD; Tina Cascone, MD, PhD; Qingqing Ding, MD, PhD; Carl Gay, MD, PhD; Robert Jenq, MD; Anil Korkut, PhD; Kristen Pauken, PhD; Nidhi Sahni, PhD; and Jihye Yun, PhD.

      MD Anderson announces 2023 class of Andrew Sabin Family Fellows

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Faculty, Genetics and Epigenetics Graduate Program (G&E), Cancer Biology Graduate Program (CBP) UTHealth Houston Graduate School of Biomedical Sciences (GSBS), The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      2010Johns Hopkins University, School of Medicine, Baltimore, Maryland, US, Cellular and Molecular Medicine Graduate Program, Ph.D

      Postgraduate Training

      2012-2016Postdoctoral Associate, Weill Cornell Medical College, Meyer Cancer Center, New York, New York
      2011-2012Postdoctoral Associate, Harvard Medical School, Boston, Massachusetts

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - 2026

      Assistant Professor, Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 2018 - 2022

      Instructor, Cancer Biology, Meyer Cancer Center, Weill Cornell Medical College, New York, NY, 2016 - 2018

      Intramural Institutional Committee Activities

      Committee Member, Odyssey Postdoctoral Fellowship Program, The University of Texas MD Anderson Cancer Center, 2024 - Present

      Co-Host and Organizer, Research Exchange Seminar Series Department of Genetics, The University of Texas MD Anderson Cancer Center, 2024 - Present

      Host and Faculty Mentor, G&E Graduate Program Rotation Talk Series, The University of Texas MD Anderson Cancer Center, 2023 - Present

      Committee Member & Institutional Representative, Internal Selection Committee Member & Institutional Representative, The University of Texas MD Anderson Cancer Center, 2023 - Present

      Extramural Institutional Committee Activities

      Committee member, Faculty Search Committee Cancer Genetics and Genomics, Baylor College of Medicine, 2019 - 2021

      Editorial Activities

      Editorial Board Member, Genes & Diseases (Elsevier), 2025 - Present

      Editorial Board Member, Nutrition and Cancer (Taylor & Francis), 2021 - Present

      Honors & Awards

      2023Andrew Sabin Family Fellowship Award, Andrew Sabin Family Foundation
      2022Rising UT STARs Award, University of Texas
      2021Phi Beta Psi Award for Cancer Research, Phi Beta Psi Charity Trust
      2020Career Enhancement Program Research Award, UT MD Anderson Cancer Center
      2020Pew-Stewart Scholar Award for Cancer Research, Pew Charitable Trusts
      2019Rosalind Franklin Young Investigator Award (Honorary Mention, 3rd Place), Genetics Society of America
      2019V Scholar Award for Cancer Research, V foundation for Cancer Research
      2017Recruitment of First-Time, Tenure-Track Faculty Members Award, Cancer Prevention and Research Institute of Texas (CPRIT)
      20171st Place winner in 2017 Young Investigators Award in Medicine, Weill Cornell Medical College
      20141st Place winner in Successful and Productive Academic Research Careers, (SPARC) Conference
      2014CTSC KL2 Scholars Award, NIH Mentored Career Development Program Weill Cornell Medical College
      2013Scholar-in-Training Award, Third AACR International Conference on Frontiers in Basic Cancer Research
      2011Damon Runyon Postdoctoral Fellowship Award, Damon Runyon Cancer Research
      20101st Place winner in Basic Research, Sidney Kimmel Comprehensive Cancer Center (SKCCC) Fellow Research Day
      2010Young Investigator Award (Mette Strand Research Award), Johns Hopkins University School of Medicine
      2009Scholars-In-Training-Award, AACR (American Association for Cancer Research) Special Meeting
      2009Outstanding Research Award, BLSA (Baltimore Life Scientist Association) Annual Meeting

      Professional Memberships

      American Association for the Advancement of Science

      2015 - Present

      American Association for Cancer Research (AACR)

      2009 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2025. Colorectal Cancer. Invited. Colorectal Cancer Moon Shot Program. Houston, Texas, US.
      2. 2024. Sugary Drinks and Young-Onset Colorectal Cancer. Invited. Moon Shots Scientific Seminar Series. Houston, Texas, US.
      3. 2024. Sugar and Colorectal Cancer. Invited. Research Town Hall. Houston, Texas, US.
      4. 2024. SORD mediates the metastatic effects of High-fructose corn syrup in colorectal cancer. Invited. Genetics and Systems Biology Joint Retreat. Houston, Texas, US.
      5. 2023. Microbiome and Young-Onset Colorectal Cancer. Invited. Research Town Hall Presentation. Houston, Texas, US.
      6. 2023. Sugary Drinks and CRC metastasis. Invited. MD Anderson-Princess Margaret Joint Symposium on Cancer Metabolism. Houston, Texas, US.
      7. 2022. Sugar and CRC. Invited. CCSG Gastrointestinal Program Research Retreat. Houston, Texas, US.
      8. 2021. Effects of Sugary Drinks on CRC. Invited. NCI-GI SPORE Investigator Annual Symposium. Houston, Texas, US.
      9. 2021. Sugar, Microbiome and CRC. Invited. Gastrointestinal/Pancreas/NET SPORE Meeting. Houston, Texas, US.
      10. 2020. Sugar, Microbiome and CRC. Invited. Research Exchange Seminar Series. Houston, Texas, US.
      11. 2019. Sugary drinks and CRC Development. Invited. MCO Distinguished Scientist Seminar Series. Houston, Texas, US.
      12. 2019. Sugar: Does it cause cancer?. Invited. 8th Annual Metabolism in Cancer Symposium,. Houston, Texas, US.

      Regional Presentations

      1. 2022. Vitamin C, Sugar and Colorectal Cancer. Invited. Baylor Students Against Cancer (BSAC). Houston, Texas, US.
      2. 2022. Sugar, Microbiome and Colorectal Cancer. Visiting. USDA-ARS Site Visit Children’s Nutrition Research Center, US.
      3. 2021. Sweet Danger of Sugary Drinks in Colorectal Cancer Development. Conference. USDA/ARS Children’s Nutrition Research Center. Houston, Texas, US.
      4. 2020. Effects of Sugary Drinks on Colorectal Cancer Development. Conference. Pediatric Gastroenterology Research Workshop. Houston, Texas, US.
      5. 2020. Sugary Drinks and Colon Cancer. Invited. Wellness Webinar, Young-Onset Colorectal Cancer Awareness. Houston, Texas, US.
      6. 2019. High-Dose Vitamin C as a Targeted Cancer Therapy. Invited. 4th Annual Korean Women in Science & Engineering Annual Conference. Houston, Texas, US.
      7. 2019. High-Fructose Corn Syrup Enhance Intestinal Tumor Growth. Invited. Baylor College of Medicine, PhD Program Retreat, Research Conference. Houston, Texas, US.
      8. 2019. High-Fructose Corn Syrup Enhance Intestinal Tumor Growth. Invited. Human Genetics Center (HGC) Seminar. Houston, Texas, US.
      9. 2019. Sugary Drinks Enhance Intestinal Tumor Growth. Conference. Molecular and Human Genetics (MHG) Annual Retreat. Houston, Texas, US.
      10. 2018. Sugary Drinks Enhance Intestinal Tumor Growth. Conference. Molecular and Cellular Biology, R&D Seminar. Houston, Texas, US.
      11. 2018. High-Fructose Corn Syrup Enhance Intestinal Tumor Growth. Invited. Texas Medical Center, Digestive Disease Center, Gastroenterology Research Forum Houston, TX. Houston, Texas, US.
      12. 2018. Effects of Diet on Colorectal Cancer. Invited. Korean-American Bio-medical Symposium. Houston, Texas, US.

      National Presentations

      1. 2026. Sweet Danger of Sugary Drinks on Colorectal Cancer. Invited. Charlottesville, VA, US.
      2. 2024. How Sugary Drinks Fuel the Spread of Colorectal Cancer. Invited. Pew Biomedical Programs Annual Retreat Meeting. Tucson, Arizona, US.
      3. 2023. Vitamin C, Microbiome, and Colitis. Invited. Cantley Laboratory Scientific Retreat. Cape cod, South Yarmouth, Massachusetts, US.
      4. 2021. Sweet Danger of Sugary Drinks in Colorectal Cancer Development. Invited. Annual Gastrointestinal (GI) SPORE Investigator Meeting, US.
      5. 2019. High-Fructose Corn Syrup Enhance Intestinal Tumor Growth. Invited. Clinical & Translation Science Center (CTSC). New York, New York, US.
      6. 2019. High-Fructose Corn Syrup Enhance Intestinal Tumor Growth. Invited. Tumor Metabolism, Keystone Symposia. Keystone, Col, US.
      7. 2017. Vitamin C, Sugar and Colorectal Cancer. Invited. Columbia University, School of Medicine, Institute for Cancer Genetics. New York, New York, US.
      8. 2017. Vitamin C, Sugar and Colorectal Cancer. Invited. Cold Spring Harbor Laboratory. Cold Spring Harbor, New York, US.
      9. 2016. Vitamin C, Sugar and Colorectal Cancer. Invited. Harvard Public School of Medicine, Genetics and Complex Disease. Boston, Massachusetts, US.
      10. 2016. Vitamin C, Sugar and Colorectal Cancer. Invited. Yale University, Cancer Biology Institute. New Heaven, Connecticut, US.
      11. 2016. Vitamin C, Sugar and Colorectal Cancer. Invited. Princeton University, Lewis-Sigler Institute for Integrative Genomics,. Princeton, New Jersey, US.
      12. 2015. Diet and Colorectal Cancer. Invited. Tri-institutions Cancer Metabolism Symposium, University of Pennsylvania. Philadelphia, Pennsylvania, US.
      13. 2014. Tumor Metabolism: High-Dose Vitamin C as a Targeted Cancer Therapy. Invited. AACR Annual Meeting. San Diego, Texas, US.

      International Presentations

      1. 2019. Sweet Danger of Sugary Drinks. Invited. 7th Helmholtz Diabetes Conference. Munich, DE.
      2. 2015. High-Dose Vitamin C as a Targeted Cancer Therapy. Invited. Molecular and Cellular Biology International Conference of the Korean Society. Seoul.

      Formal Peers

      1. 2021. Vitamin C, Sugar and Colorectal Cancer. Visiting. Houston, TX, US.
      2. 2020. Sugar, Microbiome and Colorectal Cancer. Invited. Houston, TX, US.
      3. 2020. Effects of Sugary Drinks on Colorectal Cancer Development. Invited. Houston, TX, US.
      4. 2020. Sugar, Microbiome and Colorectal Cancer. Invited. Houston, TX, US.
      5. 2019. Diet, Microbiome and Colorectal Cancer. Invited. Houston, TX, US.
      6. 2017. Sugar and Colorectal Cancer. Invited. New York, NY, US.
      7. 2016. Vitamin C and Colorectal Cancer. Invited, NY, US.
      8. 2016. Vitamin C and Colorectal Cancer. Invited. Boston, MA, US.
      9. 2016. Diet and Colorectal Cancer. Invited. New Haven, CT, US.
      10. 2016. Diet and Colorectal Cancer. Invited. Princeton, NJ, US.
      11. 2010. Young Investigators’ Day Awards Ceremony. Visiting. Baltimore, MD, US.
      12. 2009. Diet and Colorectal Cancer. Invited. Cambridge, MA, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2023 - 2025
      Title:Role of dietary sugar in humanized Apc mutant mice
      Funding Source:Colorectal Cancer Moonshot
      Role:PI
      Date: 2023 - 2028
      Title:Effects of Sugary Drinks on Colorectal Cancer Metastasis via SORD
      Funding Source:NIH/NCI
      Role:PI
      ID:R01 CA262437
      Date: 2023 - 2026
      Title:Hidden Hunger: Effects of Micronutrients on Colorectal Cancer Sabin Family Fellowship Award
      Funding Source:Andrew Sabin Family Foundation
      Role:PI
      Date: 2022 - 2025
      Title:UT STARS
      Funding Source:UT STARS Award, UTMDACC
      Role:PI
      Date: 2021 - 2025
      Title:Impact of Sugary Drinks on Colorectal Cancer Development
      Funding Source:NIH/NCI
      Role:PI
      Date: 2021 - 2024
      Title:Decoding the Sugar-Microbiome-Cancer Connection
      Funding Source:Phi Beta Psi Charity Trust
      Role:PI
      Date: 2020 - 2026
      Title:Effects of Sugary Drinks on Intestinal Microbiome, Pew-Stewart Scholar for Cancer Research
      Funding Source:Pew Charitable Trusts
      Role:PI
      Date: 2020 - 2022
      Title:Children's Nutrition Research Center/BCM Grant
      Funding Source:USDA/ARS
      Role:PI
      Date: 2020 - 2021
      Title:Dan L Duncan Comprehensive Cancer Center (DLDCC) Pilot Project Award
      Funding Source:NIH/NCI
      Role:Co-I
      ID:P30 CA125123-14
      Date: 2019 - 2023
      Title:MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
      Funding Source:NIH/NCI
      Role:Co-I
      ID:5 P50 CA221707-02
      Date: 2019 - 2022
      Title:V Scholar for Cancer Research
      Funding Source:V Foundation
      Role:PI
      Date: 2018 - 2021
      Title:NCI Transition Career Development Award
      Funding Source:NIH/NCI
      Role:PI
      ID:5 K22 CA216036-03
      Date: 2017 - 2022
      Title:Recruitment of First-Time, Tenure-Track Faculty Members Awards
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:PI
      Date: 2014 - 2016
      Title:KL2 Scholars Postdoctoral Award, Weill Cornell Medicine
      Funding Source:NIH/NCI
      Role:PI
      Date: 2011 - 2014
      Title:Damon Runyon Postdoctoral Fellowship
      Funding Source:Damon Runyon Cancer Research Foundation
      Role:PI

      Selected Publications

      Peer-Reviewed Articles

      1. Feng T, Luo Q, Liu Y, Jin Z, Skwarchuk D, Lee R, Nam M, Asara JM, Adye DR, Lorenzi PL, Tan L, Pei G, Zhao Z, Zarrin-Khameh N, Paulucci-Holthauzen A, Simons BW, Lee JS, Kopetz S, Yun J. Fructose and glucose from sugary drinks enhance colorectal cancer metastasis via SORD. Nat Metab 7(10):2018-2032, 2025. e-Pub 2025. PMID: 40973819.
      2. Tsai HY, Chen MH, Yun J, Lai LA, Valentine JF, Bronner MP, Brentnall TA, Pan S, Chen R. Restricting metabolic plasticity enhances stress adaptation through the modulation of PDH and HIF1A in TRAP1-depleted colon cancer. Cancer Lett 632:217977, 2025. e-Pub 2025. PMID: 40789509.
      3. Zhang C, Yu R, Li S, Yuan M, Hu T, Liu J, Ke H, Ye S, Yun J, Huang J, Liang G, Chen S, Wu X, Lan P. KRAS mutation increases histone H3 lysine 9 lactylation (H3K9la) to promote colorectal cancer progression by facilitating cholesterol transporter GRAMD1A expression. Cell Death Differ 32(12):2225-2238, 2025. e-Pub 2025. PMID: 40707783.
      4. Goncalves MD, Lu C, Tutnauer J, Hartman TE, Hwang SK, Murphy CJ, Pauli C, Morris R, Taylor S, Bosch K, Yang S, Wang Y, Van Riper J, Lekaye HC, Roper J, Kim Y, Chen Q, Gross SS, Rhee KY, Cantley LC, Yun J. High-fructose corn syrup enhances intestinal tumor growth in mice. Science 363(6433):1345-1349, 2019. e-Pub 2019. PMID: 30898933.
      5. Shim H, Wu C, Ramsamooj S, Bosch KN, Chen Z, Emerling BM, Yun J, Liu H, Choo-Wing R, Yang Z, Wulf GM, Kuchroo VK, Cantley LC. Deletion of the gene Pip4k2c, a novel phosphatidylinositol kinase, results in hyperactivation of the immune system. Proc Natl Acad Sci U S A 113(27):7596-601, 2016. e-Pub 2016. PMID: 27313209.
      6. Yun J, Mullarky E, Lu C, Bosch KN, Kavalier A, Rivera K, Roper J, Chio II, Giannopoulou EG, Rago C, Muley A, Asara JM, Paik J, Elemento O, Chen Z, Pappin DJ, Dow LE, Papadopoulos N, Gross SS, Cantley LC. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science 350(6266):1391-6, 2015. e-Pub 2015. PMID: 26541605.
      7. Roper J, Sinnamon MJ, Coffee EM, Belmont P, Keung L, Georgeon-Richard L, Wang WV, Faber AC, Yun J, ÖH Y, Bronson RT, Martin ES, Tsichlis PN, Hung KE. Combination PI3K/MEK inhibition promotes tumor apoptosis and regression in PIK3CA wild-type, KRAS mutant colorectal cancer. Cancer Lett 347(2):204-11, 2014. e-Pub 2014. PMID: 24576621.
      8. Parkhitko AA, Priolo C, Coloff JL, Yun J, Wu JJ, Mizumura K, Xu W, Malinowska IA, Yu J, Kwiatkowski DJ, Locasale JW, Asara JM, Choi AM, Finkel T, Henske EP. Autophagy-dependent metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide. Mol Cancer Res 12(1):48-57, 2014. e-Pub 2014. PMID: 24296756.
      9. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, Schmidt K, Willson JK, Markowitz S, Zhou S, Diaz LA, Velculescu VE, Lengauer C, Kinzler KW, Vogelstein B, Papadopoulos N. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 325(5947):1555-9, 2009. e-Pub 2009. PMID: 19661383.
      10. Lee YJ, Hong KH, Yun J, Oh SP. Generation of activin receptor type IIB isoform-specific hypomorphic alleles. Genesis 44(10):487-94, 2006. e-Pub 2006. PMID: 16991118.
      11. Seki T, Hong KH, Yun J, Kim SJ, Oh SP. Isolation of a regulatory region of activin receptor-like kinase 1 gene sufficient for arterial endothelium-specific expression. Circ Res 94(8):e72-7, 2004. e-Pub 2004. PMID: 15059937.
      12. Seki T, Yun J, Oh SP. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res 93(7):682-9, 2003. e-Pub 2003. PMID: 12970115.
      13. Yun J, Park CW, Lee YJ, Chung JH. Allele-specific methylation at the promoter-associated CpG island of mouse Copg2. Mamm Genome 14(6):376-82, 2003. e-Pub 2003. PMID: 12879359.
      14. Kim J, Hahn Y, Sohn EH, Lee YJ, Yun JH, Kim JM, Chung JH. Phenotypic variation of a Thr704Met mutation in skeletal sodium channel gene in a family with paralysis periodica paramyotonica. J Neurol Neurosurg Psychiatry 70(5):618-23, 2001. e-Pub 2001. PMID: 11309455.
      15. Hahn Y, Lee YJ, Yun JH, Yang SK, Park CW, Mita K, Huh TL, Rhee M, Chung JH. Duplication of genes encoding non-clathrin coat protein gamma-COP in vertebrate, insect and plant evolution. FEBS Lett 482(1-2):31-6, 2000. e-Pub 2000. PMID: 11018518.
      16. Lee YJ, Park CW, Hahn Y, Park J, Lee J, Yun JH, Hyun B, Chung JH. Mit1/Lb9 and Copg2, new members of mouse imprinted genes closely linked to Peg1/Mest(1). FEBS Lett 472(2-3):230-4, 2000. e-Pub 2000. PMID: 10788617.
      17. Lee J, Hahn Y, Yun JH, Mita K, Chung JH. Characterization of JDP genes, an evolutionarily conserved J domain-only protein family, from human and moths. Biochim Biophys Acta 1491(1-3):355-63, 2000. e-Pub 2000. PMID: 10760603.

      Invited Articles

      1. Ngo B, Van Riper JM, Cantley LC, Yun J. Targeting cancer vulnerabilities with high-dose vitamin C. Nat Rev Cancer 19(5):271-282, 2019. e-Pub 2019. PMID: 30967651.
      2. Yun J, Johnson JL, Hanigan CL, Locasale JW. Interactions between epigenetics and metabolism in cancers. Front Oncol 2:163, 2012. e-Pub 2012. PMID: 23162793.
      3. Yun J. Allosteric AKT inhibitors as a targeted cancer therapy. Cancer Biol Ther 9(7):504-6, 2010. e-Pub 2010. PMID: 20484970.

      Book Chapters

      1. Yun J, George P, Brown E, Klempner S, Cantley LC. MOLECULAR PATHOGENESIS OF COLORECTAL CANCER. In: MOLECULAR PATHOGENESIS OF COLORECTAL CANCER, 2013.

      Patents

      1. Goncalves M, Cantley LC, Yun J. Anti-fructose therapy for colorectal and small intestine cancers. Patent Number: 1676.145US1.
      Read More
      Less

      Patient Reviews


      CV information above last modified August 31, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • YUN LABORATORY

      • GENETICS DEPARTMENT

      • ADVANCED TECHNOLOGY GENOMICS CORE (ATGC)

      • CYTOGENETICS AND CELL AUTHENTICATION CORE (CCAC)

      • GENETICALLY ENGINEERED MOUSE FACILITY (GEMF)

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top